Healthcare Services

Global Endotoxin Testing Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Endotoxin Testing Market In 2026 And What Value Is Projected For 2030?

The endotoxin testing market size has shown substantial expansion in recent years. It is forecast to increase from $2.31 billion in 2025 to $2.44 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.5%. The expansion observed in the historic period can be ascribed to drug safety regulations, the rise in pharmaceutical manufacturing, specific medical device quality standards, prevalent patient safety concerns, and the wider reach of laboratory testing.

The endotoxin testing market is poised for significant expansion over the coming years. By 2030, this market is projected to reach $3.12 billion, demonstrating a compound annual growth rate (CAGR) of 6.3%. This anticipated growth during the forecast period stems from factors such as the rise of biologic drugs, more stringent regulatory audits, increasing automation in quality testing procedures, advancements in medical devices, and enhanced management of contamination risks. Key trends characterizing this period involve a heightened emphasis on pharmaceutical safety, the proliferation of regulatory compliance requirements, an increase in quality testing for medical devices, the broader adoption of in vitro diagnostic testing, and a persistent need for precise endotoxin detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp

What Major Drivers Are Influencing Demand In The Endotoxin Testing Market?

The endotoxin testing market is anticipated to expand due to the rising occurrence of healthcare-associated infections (HAIs). These infections are defined as those contracted during medical treatment, which were absent upon a patient’s admission to a hospital. Factors contributing to the increase in HAIs include insufficient infection prevention and control measures, contact with tainted medical equipment, and the increasing spread of drug-resistant pathogens. Through its ability to detect bacterial endotoxins in medical devices, injectable medications, and implantable products, endotoxin testing improves patient safety, mitigating the chances of sepsis, inflammation, and complications related to devices. For example, in November 2024, the Global Report on Infection Prevention and Control 2024 by the World Health Organization (WHO), a Switzerland-based public health agency also known legally as the World Health Organization, indicated that despite 71% of countries having active IPC programs, only 6% fulfilled all WHO minimum IPC requirements in 2023–2024, consequently putting millions of patients at a greater risk of HAIs. Consequently, the rising prevalence of healthcare-associated infections is fueling the expansion of the endotoxin testing market.

What Are The Key Segments Of The Endotoxin Testing Market?

The endotoxin testing market covered in this report is segmented –

1) By Test Type: LAL (Limulus Amebocyte Lysate) Test, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests, MAT Test, Rabbit Pyrogen Test, Recombinant Factor C (rFC) Assay

2) By Application: Medical Devices, Pharmaceuticals, Packaging, Raw Materials

3) By End-User: Hospitals, Laboratories, Research Institutes

Subsegments:

1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test, Kinetic LAL Test, Endpoint LAL Test

2) By Chromogenic Tests: Chromogenic LAL Test, Chromogenic Factor C Assay

3) By Turbidimetric Tests: Turbidimetric LAL Test, Turbidimetric Factor C Assay

4) By Gel Clot Tests: Gel Clot LAL Test

5) By MAT Test (Monocyte Activation Test): Direct MAT, Indirect MAT

6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test

7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection

What Major Market Trends Are Driving Changes In The Endotoxin Testing Market?

Leading companies in the endotoxin testing market are concentrating on developing sophisticated solutions, such as integrated absorbance microplate readers, to enhance testing precision, optimize laboratory processes, and strengthen adherence to data integrity standards. Advanced absorbance readers in endotoxin testing are instruments designed for seamless integration with specialized assay software, to support validated workflows, and to deliver consistent results that align with industry benchmarks. For instance, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology, and nutrition manufacturing company, launched the Nebula Absorbance Reader, a next-generation microplate reader engineered to streamline endotoxin and pyrogen testing. Fully integrated with Lonza’s latest WinKQCL software, this system facilitates data integrity compliance, reduces the burden of validation, and minimizes training needs by allowing existing WinKQCL users to operate the new reader without requiring them to learn additional software. Designed as a technologically advanced replacement for the discontinued ELx808 absorbance reader, the Nebula platform provides comparable performance and is optimized for Lonza’s absorbance-based endotoxin assays, including the PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

Who Are The Leading Companies Operating In The Endotoxin Testing Market?

Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

Read the full endotoxin testing market report here:

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Endotoxin Testing Market?

North America was the largest region in the endotoxin testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endotoxin testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Endotoxin Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12932&type=smp

Browse Through More Reports Similar to the Global Endotoxin Testing Market 2026, By The Business Research Company

Endoscopic Ultrasound Global Market Report

https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report

Primary Biliary Cholangitis Global Market Report

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

Capsule Endoscopy System Global Market Report

https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795